Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003219 · ClinicalTrials.gov registry record · Phase 2
Perillyl Alcohol in Treating Patients With Metastatic Breast Cancer
A Phase 2 study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00003219 is a Phase 2 study that has completed, run by University of Wisconsin, Madison.
The verdict
NCT00003219, a Phase 2 study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of perillyl alcohol in treating patients with metastatic breast cancer that has not responded to previous chemotherapy.
Interventions
- DRUG perillyl alcohol
Trial Details
| Field | Value |
|---|---|
| Start Date | 1998-05 |
| Est. Completion | 1998-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00003219
The ClinicalTrials.gov registry entry for NCT00003219 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which perillyl alcohol is the first listed.
NCT00003219 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00003219 about?
NCT00003219 is a clinical study titled "Perillyl Alcohol in Treating Patients With Metastatic Breast Cancer". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of perillyl alcohol in treating patients with metastatic breast cancer that has not responded to previous chemotherapy.
What is the current status of trial NCT00003219?
This trial is currently completed. It is a Phase 2 study. The study started on 1998-05. Estimated completion is 1998-05.
What interventions are being tested in trial NCT00003219?
The interventions under investigation include: perillyl alcohol (DRUG).
Who is sponsoring clinical trial NCT00003219?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.